Streetbeat News

Stock Prices

GTBP

GT Biopharma (NASDAQ:GTBP) shares surged on heavy trading volume despite no specific news. The stock is trending on Stocktwits, indicating retail trader interest. GT Biopharma recently reported better-than-expected Q1 losses and has sufficient funds to operate into 2025. The stock is up 147% today but has lost 17.55% year-to-date.

Portfolio Pulse from Erica Kollmann

May 20, 2024 | 7:00 pm

TRGP

Targa Resources (NYSE:TRGP) has seen a 12.02% increase in its short percent of float, now at 2.33% of all regular shares available for trading. This indicates a rise in bearish sentiment among investors. However, compared to its peers, Targa Resources has a lower short interest percentage.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 7:00 pm

BTCUSD

Bitcoin's price has increased by 3.12% in the past 24 hours, continuing a positive trend with a 9.0% gain over the past week. The current price is $68,652.00, with a trading volume decrease of 10.0% and a circulating supply of 19.70 million BTC.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 7:00 pm

NBY

NovaBay Pharmaceuticals Inc (NASDAQ:NBY) shares surged by 50% to $0.18 despite no new company-specific news. The rise follows last week's launch of new Avenova product bundles for dry eye relief, aligning with the 2024 Eyes on Eyecare Dry Eye Report. CEO Justin Hall highlighted the growing prevalence of dry eye syndrome and the expected market growth from $3.02 billion in 2023 to $4.86 billion by 2030.

Portfolio Pulse from Henry Khederian

May 20, 2024 | 6:59 pm

NFLX

Netflix shares are trading higher following a bullish rating reiteration by Wedbush.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 6:59 pm

INTU

SNOW

WDAY

ZM

JPMorgan analyst Mark Murphy issued ratings for enterprise software companies Zoom, Snowflake, Intuit, and Workday, highlighting short-term volatility but long-term growth potential. Murphy gave Neutral ratings to Zoom and Intuit, and Overweight ratings to Snowflake and Workday.

Portfolio Pulse from Hayden Buckfire

May 20, 2024 | 6:53 pm

MRX

Analysts have initiated coverage on Marex Group (NASDAQ:MRX) with positive ratings and price targets, following its IPO last month. The company reported strong financial results for fiscal 2023, indicating substantial growth.

Portfolio Pulse from Vaishali Prayag

May 20, 2024 | 6:50 pm

LRCX

The article discusses the recent options trading activity for Lam Research (NASDAQ:LRCX), highlighting a bullish sentiment among large investors. The majority of trades were calls, indicating positive expectations for the stock. Analysts have mixed ratings, with price targets ranging from $850 to $1150.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 6:45 pm

BTBT

BTCT

CLSK

MARA

MSTR

RIOT

WULF

Shares of crypto-related stocks are trading higher amid a rise in Bitcoin.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 6:43 pm

AMGN

AZN

Amgen and AstraZeneca announced results from the Phase 2a COURSE trial of Tezspire for severe COPD, showing mixed efficacy results. The drug showed a 17% reduction in COPD exacerbations overall, but more significant reductions in specific patient subgroups. The safety profile was consistent with its approved severe asthma indication.

Portfolio Pulse from Vandana Singh

May 20, 2024 | 6:38 pm